Enveric Biosciences, Inc. (ENVB) NASDAQ

2.22

-0.04(-1.77%)

Updated at June 02 04:00PM

Currency In USD

Enveric Biosciences, Inc.

Address

4851 Tamiami Trail North

Naples, FL 34103

United States of America (the)

Phone

239 302 1707

Sector

Healthcare

Industry

Biotechnology

Employees

5

First IPO Date

May 04, 2015

Key Executives

NameTitlePayYear Born
Joseph Edward TuckerChief Executive Officer & Director472,3991969
Peter J. FacchiniChief Innovation Officer221,7811964
Kevin CoveneyChief Financial Officer396,5501964

Description

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.